IVS

Listed Company · HNX

Price
6,900
Latest close
03 Apr 2026
P/E 55.6x
EPS (TTM) 124
ROE (TTM)
P/B 0.6x
BVPS (Latest) 11,197
ROA (TTM)

What Is Changing

IVS is entering a phase where earnings quality matters more than pure top-line recovery. The next question is whether current profit momentum can hold through the next cycle.

  • Quarterly Net Income decreased 202.7% QoQ to VND -4.4bn in 2025Q4.
Metric 2025
Revenue 107.0
Growth
Net Income 13.1
Net Margin 12.21%

Financial Statements

Profitability

Net margin reached 12.21% and still needs validation through the next few periods.

Balance Sheet

Inventory stood at 0.0bn, liabilities at 365.3bn, and equity at 1,174.8bn.

Cash Flow

Compare operating cash flow against investment needs to judge growth quality.

None

Item 2025
Net Revenue
107.0
Cost of Goods Sold
0.0
Gross Profit
81.3
Financial Expenses
9.4
Selling Expenses
0.0
General and Administrative Expenses
54.3
Operating Profit
17.9
Profit Before Tax
17.9
Net Income
13.1
Profit Attributable to Parent
13.1
Earnings per Share
132.00

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.